The IMID Forum
autor: The Immune-Mediated Inflammatory Disease Forum
Najnowszy odcinek
Author Interview: Doctor André Lucas Ribeiro, November 2026
Author Interview: Doctor André Lucas Ribeiro, November 2026
O tym podcaście
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Odcinki
Najnowsze 50 z 429 odcinków
- Author Interview: Doctor André Lucas Ribeiro, November 2026 · 31 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Doctor André Lucas Ribeiro, a Rheumatologist at the Hospital de Clínicas de Porto Alegre Porto Alegre, in…
- ACR 2026: Daily Highlights: Day 4 · 3 minJoin Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 4 of ACR 2026 (Wednesday 11th November)
- ACR 2026: Daily Highlights Day 3 · 5 minJoin Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 3 of ACR 2026 (Tuesday 10th November)
- ACR 2026 Daily Highlights: Day 2 · 4 minJoin Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 2 of ACR 2026 (Monday 9th November)
- ACR 2026 Daily Highlights: Day 1 · 4 minJoin Doctor Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of ACR 2026 (Sunday 8th November)
- ACR 2026 Preview Podcast · 21 minJoin Doctor Sofia Ramiro and Professor Phillip Mease as they preview what they are most looking forward to this ACR, introducing some of the top chosen abstracts and posters in…
- Discussing RA: Comparative safety and remission outcomes of targeted therapies and MTX · 13 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Ibis et al. and…
- Author Interview: Doctor Mark Gibson, October 2026 · 38 minJoin Professor Peter Nash from Griffith University in Brisbane and Doctor Mark Gibson from the Centre for Rheumatic Diseases, King’s College London, as they discuss Doctor…
- Discussing PsA: Difficult-to-manage PsA and molecular and clinical responses to zasocitinib · 17 minJoin Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions…
- Discussing RA: Impact of BMI on response to JAK inhibitors in RA · 7 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review paper by Bechman et al…
- Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials · 20 minJoin Dr Sofia Ramiro and Dr Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered whether men and women with axSpA respond…
- Author Interview: Doctor Elise van Mulligen, September 2026 · 21 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they…
- Discussing RA: Biologic effectiveness and treatment persistence in RA · 9 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and…
- Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety · 24 minJoin Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s…
- Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026 · 27 minJoin Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland…
- Discussing RA: Advanced therapy outcomes in RA · 27 minJoin Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key…
- Author Interview: Professor Laura Coates, July 2026 · 27 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology…
- Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA · 24 minJoin Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy…
- Author Interview: Dr Murat Torgutalp, June 2026 · 29 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Dr Murat Torgutalp, from the Charité – Universitätsmedizin in Berlin, as they discuss his recent paper…
- Discussing RA: Infectious complications of RA treatments · 10 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two recent studies by Etani…
- Author Interview: Doctor Chung-Mao Kao, May 2026 · 14 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Doctor Chung-Mao Kao from Taichung Veterans General Hospital, as they discuss the recent publication…
- Discussing PsA: Personalising treatment targets – understanding clinically meaningful improvement · 13 minJoin Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in psoriatic arthritis…
- EULAR 2026 Review Podcast · 40 minJoin Professors Xenofon Baraliakos, Laura Coates and Dr Sofia Ramiro as they break down the top RA, PsA and axSpA abstracts, sessions and posters from this year's EULAR conference.
- EULAR 2026 Day 4 Highlights Podcast · 5 minJoin Professor Sofia Ramiro as she summarises her top RA, PsA and axSpA abstracts, posters, and presentations for Day 4 of EULAR 2026 (Saturday, June 6th).
- EULAR 2026 Day 3 Highlights Podcast · 3 minJoin Professor Sofia Ramiro as she summarises her top RA, PsA and axSpA abstracts, posters, and presentations for Day 3 of EULAR 2026 (Friday, June 5th).
- EULAR 2026 Day 2 Highlights Podcast · 6 minJoin Professor Sofia Ramiro as she summarises her top RA, PsA and axSpA abstracts, posters, and presentations for Day 2 of EULAR 2026 (Thursday, June 4th).
- EULAR 2025 Day 1 Highlights Podcast · 6 minJoin Professor Sofia Ramiro as she summarises her top RA, PsA and axSpA abstracts, posters, and presentations for Day 1 of EULAR 2026 (Wednesday, June 3rd).
- Discussing RA: Comparative outcomes with upadacitinib in RA · 9 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Mysler et al. and…
- EULAR 2026 Preview Podcast · 22 minJoin Professor Xenofon Baraliakos as he guides you through what we are most looking forward to in RA, PsA, and axSpA at EULAR 2026, so that you can better plan your time at what…
- Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis · 22 minJoin Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces…
- Author Interview: Professor Valentino Paci, April 2026 · 40 minJoin Professor Peter Nash from the Griffith University in Brisbane, and am Professor Valentino Paci, Medical researcher specialized in immune-mediated diseases, with a particular…
- Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure · 14 minJoin Professor Iain McInnes and Professor Rieke Alten for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they will review…
- Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile · 17 minJoin Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of…
- Author Interview: Professor Helena Marzo-Ortega, March 2026 · 38 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Professor Helena Marzo-Ortega an academic clinician and the Clinical Lead of the multi-award winning Leeds…
- Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions · 10 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the…
- Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers · 33 minJoin Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of shorter versus longer…
- Author Interview: Doctor Carlo Tur, February 2026 · 30 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Doctor Carlo Tur, from the department of Medicine 3-Rheumatology and Immunology…
- Author Interview - Professor Andrew Cope, 2026 · 25 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College London, London, UK, as they…
- Discussing RA: Pain outcomes and drug effectiveness of JAK inhibitors in RA and PsA · 9 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Taylor et al…
- Discussing PsA: Risankizumab efficacy across machine learning defined and complex PsA phenotypes · 21 minJoin Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘classification of patients into…
- Author Interview: Professor Matthew Brown, 2026 · 18 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as they discuss his recent…
- Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis · 9 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Strand et al…
- Discussing RA: UPA outcomes and the impact of GCs on targeted therapies in RA · 23 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor Reike Alten will be…
- Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab · 13 minJoin Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective…
- Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA · 21 minJoin Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of…
- Discussing RA: Real-world evaluation of JAKi efficacy, persistence, and cardiovascular safety in RA · 10 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review two papers. The first…
- Author Interview: Professor Filip Rob, 2025 · 25 minJoin Professor Peter Nash from the Griffith University in Brisbane, and Professor Filip Rob, the Department of head of the Dermatovenereology at the Second Faculty of Medicine…
- Webinar Highlights: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs: Part 2 · 17 minWebinar highlights! Join Professor Iain McInnes and Drs Grace Wright and Melinda Gooderham as they discuss advancing patient care through an interdisciplinary approach to IMIDs…
- Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis · 15 minJoin Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between…
- Discussing RA: Long-term management of elderly patients with RA treated with tocilizumab · 5 minJoin Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, Iain will review a paper by B Fautrel, in…








